Afanat 30mg Tablet
Rs. 3,758.00
Title
Afanat 30mg Tablet
Prescription drug
Expiry
:
30-11-2028
About Afanat 30mg Tablet contains afatinib dimaleate, an oral tyrosine kinase inhibitor used in the treatment of appropriate EGFR mutation positive non-small cell lung cancer and other approved indications.
Usage Instructions Take exactly as prescribed by an oncologist, usually once daily on an empty stomach. Do not alter the dose without medical advice.
Benefits Helps slow the growth and spread of certain cancer cells by targeting EGFR and related growth receptors.
How it Works Afatinib irreversibly inhibits EGFR, HER2 and HER4 receptors involved in cancer cell growth signalling.
Side Effects Diarrhoea, rash, mouth ulcers, loss of appetite, dry skin, fatigue and nail changes may occur.
Safety Advice Strictly prescription only. Requires oncologist supervision and regular monitoring. Inform your doctor about lung, liver, kidney or heart conditions.
Storage Store below 30°C in a dry place, away from direct sunlight and out of reach of children.
Usage Instructions Take exactly as prescribed by an oncologist, usually once daily on an empty stomach. Do not alter the dose without medical advice.
Benefits Helps slow the growth and spread of certain cancer cells by targeting EGFR and related growth receptors.
How it Works Afatinib irreversibly inhibits EGFR, HER2 and HER4 receptors involved in cancer cell growth signalling.
Side Effects Diarrhoea, rash, mouth ulcers, loss of appetite, dry skin, fatigue and nail changes may occur.
Safety Advice Strictly prescription only. Requires oncologist supervision and regular monitoring. Inform your doctor about lung, liver, kidney or heart conditions.
Storage Store below 30°C in a dry place, away from direct sunlight and out of reach of children.
₹3,758.00
MRP: ₹3,956.25
Save ₹198.25
(5%)
Inclusive of all taxes
Quantity
Fresh Stock
Guaranteed
Guaranteed
Secure & Hygienic
Packaging
Packaging
Verified & Trusted
Supplements
Supplements
Secure
Payment
Payment
About Afanat 30mg Tablet contains afatinib dimaleate, an oral tyrosine kinase inhibitor used in the treatment of appropriate EGFR mutation positive non-small cell lung cancer and other approved indications.
Usage Instructions Take exactly as prescribed by an oncologist, usually once daily on an empty stomach. Do not alter the dose without medical advice.
Benefits Helps slow the growth and spread of certain cancer cells by targeting EGFR and related growth receptors.
How it Works Afatinib irreversibly inhibits EGFR, HER2 and HER4 receptors involved in cancer cell growth signalling.
Side Effects Diarrhoea, rash, mouth ulcers, loss of appetite, dry skin, fatigue and nail changes may occur.
Safety Advice Strictly prescription only. Requires oncologist supervision and regular monitoring. Inform your doctor about lung, liver, kidney or heart conditions.
Storage Store below 30°C in a dry place, away from direct sunlight and out of reach of children.
Usage Instructions Take exactly as prescribed by an oncologist, usually once daily on an empty stomach. Do not alter the dose without medical advice.
Benefits Helps slow the growth and spread of certain cancer cells by targeting EGFR and related growth receptors.
How it Works Afatinib irreversibly inhibits EGFR, HER2 and HER4 receptors involved in cancer cell growth signalling.
Side Effects Diarrhoea, rash, mouth ulcers, loss of appetite, dry skin, fatigue and nail changes may occur.
Safety Advice Strictly prescription only. Requires oncologist supervision and regular monitoring. Inform your doctor about lung, liver, kidney or heart conditions.
Storage Store below 30°C in a dry place, away from direct sunlight and out of reach of children.